Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters
Plus, it's gluten-free, lactose-free, and vegan-friendly, so it's perfect for everyone, no matter your diet
Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis
Studies in patients with diabetes have shown that at the 28-week mark, people taking 1 mg of semaglutide lose approximately 7% of their weight
Human research remains limited but is expanding
In November 2023, AstraZeneca and Eccogene signed an exclusive license agreement for ECC5004, an investigational oral once-daily GLP-1RA for treating obesity, type 2 diabetes, and other cardiometabolic conditions